stella
beta
Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease — Stella
Home
/
Extramedullary Multiple Myeloma
/
Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease
View on ClinicalTrials.gov
Recruiting
Back to Extramedullary Multiple Myeloma trials
Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
China
Beijing Gobroad Boren Hospital, Beijing
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin